The comparison between the groups revealed significantly higher levels of Flt3L in the blood of the survivin-positive RA patients compared to survivin-negative (pg/ml: 110 [range 30–3320] vs 70 [range 10–230], p = 0.003, Fig. 1A). This evidence concerns the gene FLT3LG and rheumatoid arthritis.